Cirrhosis clinical trials

Explore recruiting cirrhosis clinical trials.

Recruiting cirrhosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cirrhosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Spain, Hungary, Netherlands, Belgium, Bulgaria, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection

France, Austria, Germany, Romania, Belgium, Spain +1 more

Therapeutic use (Phase IV) EU CTIS Study details

LIVER AKI: A randomized, open-label trial to evaluate the efficacy of intravenous human albumin administration versus saline solution (NaCl 0.9%) in patients with decompensated cirrhosis and AKI 1B or grater.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Safety and efficacy of a human albumin solution with restored structural profile in patients with decompensated cirrhosis

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Encapsulated Fecal Microbiota Transfer to Treat Immune Activation in Patients with Cirrhosis and Ascites (TransImmune) – A randomized, double-blind, placebo-controlled phase IIa clinical pilot study

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A novel COMBinATorial therapy with albumin and enoxaparin in patients with decompensated cirrhosis at high-risk of poor outcome (COMBAT trial).

Spain, Italy, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Cirrhosis trials by city

Cirrhosis in Toronto Cirrhosis in Vancouver Cirrhosis in Montreal Cirrhosis in Calgary Cirrhosis in Edmonton Cirrhosis in Ottawa Cirrhosis in Winnipeg Cirrhosis in Quebec City Cirrhosis in Hamilton Cirrhosis in Kitchener Cirrhosis in London Cirrhosis in Halifax Cirrhosis in New York Cirrhosis in Los Angeles Cirrhosis in Chicago Cirrhosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease